These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Sun Z, Zhang Y. Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264 [Abstract] [Full Text] [Related]
8. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Scorpio A, Zhang Y. Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557 [Abstract] [Full Text] [Related]
12. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. Zhang Y, Scorpio A, Nikaido H, Sun Z. J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680 [Abstract] [Full Text] [Related]
14. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. Tuber Lung Dis; 1997 Apr; 78(2):117-22. PubMed ID: 9692180 [Abstract] [Full Text] [Related]